These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 28501618

  • 1. Assessing activity of Hepatitis A virus 3C protease using a cyclized luciferase-based biosensor.
    Zhou J, Wang D, Xi Y, Zhu X, Yang Y, Lv M, Luo C, Chen J, Ye X, Fang L, Xiao S.
    Biochem Biophys Res Commun; 2017 Jul 08; 488(4):621-627. PubMed ID: 28501618
    [Abstract] [Full Text] [Related]

  • 2. Disruption of TLR3 signaling due to cleavage of TRIF by the hepatitis A virus protease-polymerase processing intermediate, 3CD.
    Qu L, Feng Z, Yamane D, Liang Y, Lanford RE, Li K, Lemon SM.
    PLoS Pathog; 2011 Sep 08; 7(9):e1002169. PubMed ID: 21931545
    [Abstract] [Full Text] [Related]

  • 3. Hepatitis A virus 3C protease cleaves NEMO to impair induction of beta interferon.
    Wang D, Fang L, Wei D, Zhang H, Luo R, Chen H, Li K, Xiao S.
    J Virol; 2014 Sep 01; 88(17):10252-8. PubMed ID: 24920812
    [Abstract] [Full Text] [Related]

  • 4. Identification of Mulberrofuran as a potent inhibitor of hepatitis A virus 3Cpro and RdRP enzymes through structure-based virtual screening, dynamics simulation, and DFT studies.
    Sureshan M, Brintha S, Jothi A.
    Mol Divers; 2024 Jun 01; 28(3):1609-1628. PubMed ID: 37386350
    [Abstract] [Full Text] [Related]

  • 5. Development of a luciferase-based biosensor to assess enterovirus 71 3C protease activity in living cells.
    Zhang Y, Ke X, Zheng C, Liu Y, Xie L, Zheng Z, Wang H.
    Sci Rep; 2017 Sep 04; 7(1):10385. PubMed ID: 28871120
    [Abstract] [Full Text] [Related]

  • 6. Degradation of the encephalomyocarditis virus and hepatitis A virus 3C proteases by the ubiquitin/26S proteasome system in vivo.
    Schlax PE, Zhang J, Lewis E, Planchart A, Lawson TG.
    Virology; 2007 Apr 10; 360(2):350-63. PubMed ID: 17150238
    [Abstract] [Full Text] [Related]

  • 7. Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor.
    Yang Y, Liang Y, Qu L, Chen Z, Yi M, Li K, Lemon SM.
    Proc Natl Acad Sci U S A; 2007 Apr 24; 104(17):7253-8. PubMed ID: 17438296
    [Abstract] [Full Text] [Related]

  • 8. Porcine Epidemic Diarrhea Virus 3C-Like Protease Regulates Its Interferon Antagonism by Cleaving NEMO.
    Wang D, Fang L, Shi Y, Zhang H, Gao L, Peng G, Chen H, Li K, Xiao S.
    J Virol; 2016 Feb 15; 90(4):2090-101. PubMed ID: 26656704
    [Abstract] [Full Text] [Related]

  • 9. Hepatitis A virus (HAV) proteinase 3C inhibits HAV IRES-dependent translation and cleaves the polypyrimidine tract-binding protein.
    Kanda T, Gauss-Müller V, Cordes S, Tamura R, Okitsu K, Shuang W, Nakamoto S, Fujiwara K, Imazeki F, Yokosuka O.
    J Viral Hepat; 2010 Sep 15; 17(9):618-23. PubMed ID: 19889140
    [Abstract] [Full Text] [Related]

  • 10. Proteinase 3C of hepatitis A virus (HAV) cleaves the HAV polyprotein P2-P3 at all sites including VP1/2A and 2A/2B.
    Schultheiss T, Kusov YY, Gauss-Müller V.
    Virology; 1994 Jan 15; 198(1):275-81. PubMed ID: 8259663
    [Abstract] [Full Text] [Related]

  • 11. Identification and site-directed mutagenesis of the primary (2A/2B) cleavage site of the hepatitis A virus polyprotein: functional impact on the infectivity of HAV RNA transcripts.
    Martin A, Escriou N, Chao SF, Girard M, Lemon SM, Wychowski C.
    Virology; 1995 Oct 20; 213(1):213-22. PubMed ID: 7483265
    [Abstract] [Full Text] [Related]

  • 12. Hepatitis A virus polyprotein processing by Escherichia coli proteases.
    Pintó RM, Guix S, González-Dankaart JF, Caballero S, Sánchez G, Guo KJ, Ribes E, Bosch A.
    J Gen Virol; 2002 Feb 20; 83(Pt 2):359-368. PubMed ID: 11807229
    [Abstract] [Full Text] [Related]

  • 13. Poly(A) binding protein, C-terminally truncated by the hepatitis A virus proteinase 3C, inhibits viral translation.
    Zhang B, Morace G, Gauss-Müller V, Kusov Y.
    Nucleic Acids Res; 2007 Feb 20; 35(17):5975-84. PubMed ID: 17726047
    [Abstract] [Full Text] [Related]

  • 14. Crystal structure of an inhibitor complex of the 3C proteinase from hepatitis A virus (HAV) and implications for the polyprotein processing in HAV.
    Bergmann EM, Cherney MM, Mckendrick J, Frormann S, Luo C, Malcolm BA, Vederas JC, James MN.
    Virology; 1999 Dec 05; 265(1):153-63. PubMed ID: 10603326
    [Abstract] [Full Text] [Related]

  • 15. Functional binding of hexanucleotides to 3C protease of hepatitis A virus.
    Blaum BS, Wünsche W, Benie AJ, Kusov Y, Peters H, Gauss-Müller V, Peters T, Sczakiel G.
    Nucleic Acids Res; 2012 Apr 05; 40(7):3042-55. PubMed ID: 22156376
    [Abstract] [Full Text] [Related]

  • 16. Protease 3C of hepatitis A virus induces vacuolization of lysosomal/endosomal organelles and caspase-independent cell death.
    Shubin AV, Demidyuk IV, Lunina NA, Komissarov AA, Roschina MP, Leonova OG, Kostrov SV.
    BMC Cell Biol; 2015 Feb 27; 16():4. PubMed ID: 25886889
    [Abstract] [Full Text] [Related]

  • 17. Dual modes of modification of hepatitis A virus 3C protease by a serine-derived beta-lactone: selective crystallization and formation of a functional catalytic triad in the active site.
    Yin J, Bergmann EM, Cherney MM, Lall MS, Jain RP, Vederas JC, James MN.
    J Mol Biol; 2005 Dec 09; 354(4):854-71. PubMed ID: 16288920
    [Abstract] [Full Text] [Related]

  • 18. A 3C(pro)-dependent bioluminescence imaging assay for in vivo evaluation of anti-enterovirus 71 agents.
    Guo Z, Zhong X, Lin L, Wu S, Wang T, Chen Y, Zhai X, Wang Y, Wu H, Tong L, Han Y, Pan B, Peng Y, Si X, Zhang F, Zhao W, Zhong Z.
    Antiviral Res; 2014 Jan 09; 101():82-92. PubMed ID: 24263113
    [Abstract] [Full Text] [Related]

  • 19. New 4-phenylcoumarin derivatives as potent 3C protease inhibitors: Design, synthesis, anti-HAV effect and molecular modeling.
    Kassem AF, Batran RZ, Abbas EMH, Elseginy SA, Shaheen MNF, Elmahdy EM.
    Eur J Med Chem; 2019 Apr 15; 168():447-460. PubMed ID: 30844608
    [Abstract] [Full Text] [Related]

  • 20. An episulfide cation (thiiranium ring) trapped in the active site of HAV 3C proteinase inactivated by peptide-based ketone inhibitors.
    Yin J, Cherney MM, Bergmann EM, Zhang J, Huitema C, Pettersson H, Eltis LD, Vederas JC, James MN.
    J Mol Biol; 2006 Aug 25; 361(4):673-86. PubMed ID: 16860823
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.